Literature DB >> 11240754

Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases.

S.A. Szukala1, J.R. Marks, J.L. Burchette, A.A. Elbendary, H.R. Krigman.   

Abstract

Carcinosarcoma is an aggressive neoplasm of the female genital tract, which comprises 1-2% of malignancies of the uterine corpus. Because of the broad range of differentiation exhibited by these tumors, the precise nature of the relationship between epithelial and stromal components in this unique tumor remain unclear. Previous studies have demonstrated that mutation and consequent overexpression of the tumor suppressor gene p53 occurs frequently in carcinosarcoma and is conserved from primary to metastastic sites. We examined p53 accumulation in formalin-fixed, paraffin-embedded archival sections in 19 cases previously shown to have mutations in the p53 gene and performed semi-quantitative analysis of the intensity of staining and relative density of positive cells and stromal and glandular elements. There was a high level of concordance of immunohistochemical staining for the p53 oncoprotein between glandular and stromal elements. These results further suggest a clonal origin for the diverse elements of carcinosarcoma.

Entities:  

Year:  1999        PMID: 11240754     DOI: 10.1046/j.1525-1438.1999.09905.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

2.  Which is worse: uterine papillary serous carcinomas or carcinosarcomas?

Authors:  Taejong Song; Chel Hun Choi; Yoo-Young Lee; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

Review 3.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

4.  Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study.

Authors:  Tadao Takano; Takeo Otsuki; Hideki Tokunaga; Masafumi Toyoshima; Hiroki Utsunomiya; Satoru Nagase; Hitoshi Niikura; Kiyoshi Ito; Nobuo Yaegashi; Hidekazu Yamada; Toru Tase; Masahiro Kagabu; Tadahiro Shoji; Toru Sugiyama; Naoki Sato; Toshio Fujimoto; Yukihiro Terada; Kenji Nakahara; Hirohisa Kurachi; Yoshihito Yokoyama; Hideki Mizunuma; Shu Soeda; Hiroshi Nishiyama; Takashi Matsumoto; Shinya Sato; Muneaki Shimada; Junzo Kigawa
Journal:  Int J Clin Oncol       Date:  2014-01-07       Impact factor: 3.402

Review 5.  Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Authors:  Khadra Galaal; Keith Godfrey; Raj Naik; Ali Kucukmetin; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 6.  Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Authors:  Khadra Galaal; Esther van der Heijden; Keith Godfrey; Raj Naik; Ali Kucukmetin; Andrew Bryant; Nagindra Das; Alberto D Lopes
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  [p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumor aggressiveness in humans].

Authors:  P J Wild
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

8.  p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans.

Authors:  Peter J Wild; Kristian Ikenberg; Thomas J Fuchs; Markus Rechsteiner; Strahil Georgiev; Niklaus Fankhauser; Aurelia Noske; Matthias Roessle; Rosmarie Caduff; Athanassios Dellas; Daniel Fink; Holger Moch; Wilhelm Krek; Ian J Frew
Journal:  EMBO Mol Med       Date:  2012-06-08       Impact factor: 12.137

9.  miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.

Authors:  Jill H Tseng; Maria Bisogna; Lien N Hoang; Narciso Olvera; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K Sood; Douglas A Levine; Petar Jelinic
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.